Partial Response to Platinum Doublets in Refractory EGFR-Positive Non-Small Cell Lung Cancer Patients after RRx-001: Evidence of Episensitization

Publisher： Karger

E-ISSN： 1662-6575|9|1|62-67

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.9, Iss.1, 2016-01, pp. : 62-67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum Doublets

By  

Case Reports in Oncology, Vol. 9, Iss. 2, 2016-05 ,pp. : 285-289

Karger

Access to resources Recommend Favorite

RRx-001 in Refractory Small-Cell Lung Carcinoma: A Case Report of a Partial Response after a Third Reintroduction of Platinum Doublets

By  

Case Reports in Oncology, Vol. 9, Iss. 1, 2016-03 ,pp. : 171-176

Karger

Access to resources Recommend Favorite

Metabolic Response Assessment in Non-Small Cell Lung Cancer Patients after Platinum-Based Therapy: A Preliminary Analysis

By  

Current Medical Imaging Reviews, Vol. 11, Iss. 4, 2015-01 ,pp. : 218-227

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Predictors of Response to EGFR Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Non-Small Cell Lung Cancer

By  

Oncology, Vol. 86, Iss. 2, 2014-01 ,pp. : 86-93

Karger

Access to resources Recommend Favorite

Challenges in the Management of EGFR-Mutated Non-Small Cell Lung Cancer Patients with Acquired Resistance to Tyrosine Kinase Inhibitors

By  

Oncology, Vol. 87, Iss. 2, 2014-07 ,pp. : 83-94

Karger

Access to resources Recommend Favorite